More importantly, Egfl7 has already been evidenced to be upregulated in the serum of patients with HCC or other type of cancers [32, 49–51], suggesting its possible application in the diagnosis of HCC. The gene discussed is EGFL7; the disease is hepatocellular carcinoma.